Journal Gatekeeping:

Are medical journals increasingly acting as ‘gatekeepers’ to promote ‘established narratives’ but sideline research that challenges the status quo? Many articles containing  ‘controversial’ views that initially achieved publication have been promptly retracted. In the past 5 years, the retraction of papers criticizing the covid vaccines or lockdown policies, for example, has gone stratospheric….

Read More

Divide and Conquer

Our drug safety monitoring systems are designed to identify an increase in the incidence of a rare condition. That is why they worked relatively well at identifying the Cerebral Venous Sinus Thrombosis and myocarditis cases. They are bad at identifying increases in more common conditions and terrible at identifying multi-system conditions.

Read More

6-month cardiac follow-up data finally arrives

In August 2021, the JCVI said they wanted to delay a decision about children’s covid vaccines until 6-month followup data was available on children from the US who had sustained vaccine-induced myocarditis. But instead of waiting, they passed the decision to the Chief Medical Officers, who decided the jabs would be good for children’s mental health! Well the data is now in and it is not encouraging.

Read More

Covid-19 Response and Excess Deaths

On 18th April, Andrew Bridgen finally secured a full length debate on this vexed topic, the original text of which is available here. Full length in theory, but shortly before the debate was due to begin, the deputy Speaker told him he only had 15 minutes instead of the 30 minutes he had prepared. After a complaint to the Speaker’s office the compromise was 20 minutes.

Read More

Have the MHRA admitted causation for any vaccine harm?

The MHRA are far too slow to react to harm and admit causation. There is a history here. When the 2009 swine flu vaccine caused narcolepsy the UK institutions were very slow to react. It was Scandinavian countries who highlighted the problem in 2010. That year the MHRA were measuring for other effects but not narcolepsy. In 2011, they said they needed to await epidemiological studies. It took until 2013 before Public Health England admitted a problem in the UK.

Read More

When money and ethics collide

Last month, HART wrote an article on the spring booster programme, including linking to an article in Chemist+Druggist on the pending availability of private covid vaccines in pharmacies up and down the land. A company called Pharmadoctor was the first into the ring but has been followed by others including Boots, the oldest of the UK high street chemists, whose strapline on their website is: We serve your wellbeing for life.

Read More